Sandy Spring Bank’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$14.5M Sell
29,208
-396
-1% -$214K 0.61% 35
2024
Q4
$15.4M Buy
29,604
+12
+0% +$6.6K 0.62% 33
2024
Q3
$18.3M Sell
29,592
-345
-1% -$204K 0.75% 28
2024
Q2
$16.6M Buy
29,937
+415
+1% +$238K 0.73% 26
2024
Q1
$17.2M Buy
29,522
+157
+0.5% +$88.1K 0.78% 27
2023
Q4
$15.6M Buy
29,365
+930
+3% +$450K 0.78% 26
2023
Q3
$14.4M Buy
28,435
+127
+0.4% +$67.7K 0.8% 26
2023
Q2
$14.8M Buy
28,308
+981
+4% +$529K 0.79% 27
2023
Q1
$15.8M Buy
27,327
+232
+0.9% +$131K 0.89% 22
2022
Q4
$14.9M Sell
27,095
-713
-3% -$378K 0.89% 23
2022
Q3
$14.1M Sell
27,808
-1,199
-4% -$671K 0.89% 24
2022
Q2
$15.8M Sell
29,007
-578
-2% -$318K 0.95% 21
2022
Q1
$17.5M Buy
29,585
+749
+3% +$430K 0.89% 24
2021
Q4
$19.2M Buy
28,836
+238
+0.8% +$149K 0.92% 25
2021
Q3
$16.3M Sell
28,598
-207
-0.7% -$114K 0.87% 26
2021
Q2
$14.5M Buy
28,805
+1,474
+5% +$695K 0.77% 30
2021
Q1
$12.5M Buy
27,331
+966
+4% +$461K 0.72% 28
2020
Q4
$12.3M Buy
26,365
+646
+3% +$303K 0.75% 28
2020
Q3
$11.4M Buy
25,719
+931
+4% +$385K 0.78% 25
2020
Q2
$8.98M Buy
24,788
+856
+4% +$287K 0.67% 35
2020
Q1
$6.79M Buy
23,932
+1,199
+5% +$378K 0.61% 39
2019
Q4
$7.38M Sell
22,733
-18
-0.1% -$5.46K 0.54% 48
2019
Q3
$6.63M Buy
22,751
+986
+5% +$282K 0.52% 52
2019
Q2
$6.39M Buy
21,765
+1,625
+8% +$448K 0.51% 49
2019
Q1
$5.51M Buy
20,140
+1,655
+9% +$412K 0.47% 58
2018
Q4
$4.14M Buy
18,485
+1,594
+9% +$374K 0.4% 69
2018
Q3
$4.12M Buy
16,891
+1,707
+11% +$393K 0.34% 80
2018
Q2
$3.15M Buy
15,184
+2,457
+19% +$522K 0.27% 97
2018
Q1
$2.63M Buy
12,727
+1,147
+10% +$241K 0.23% 117
2017
Q4
$2.2M Buy
11,580
+98
+0.9% +$18.8K 0.2% 137
2017
Q3
$2.17M Sell
11,482
-181
-2% -$32.8K 0.21% 130
2017
Q2
$2.03M Sell
11,663
-298
-2% -$50.1K 0.2% 136
2017
Q1
$1.84M Sell
11,961
-135
-1% -$20.6K 0.18% 144
2016
Q4
$1.71M Buy
12,096
+785
+7% +$116K 0.18% 152
2016
Q3
$1.8M Sell
11,311
-150
-1% -$23.1K 0.19% 142
2016
Q2
$1.69M Buy
11,461
+490
+4% +$72.3K 0.19% 139
2016
Q1
$1.55M Buy
10,971
+2,123
+24% +$285K 0.18% 144
2015
Q4
$1.25M Buy
8,848
+1,181
+15% +$158K 0.15% 159
2015
Q3
$937K Buy
7,667
+1,684
+28% +$219K 0.11% 177
2015
Q2
$776K Buy
5,983
+2,508
+72% +$327K 0.09% 185
2015
Q1
$467K Buy
3,475
+1,100
+46% +$142K 0.05% 221
2014
Q4
$298K Buy
+2,375
New +$289K 0.04% 232

Other funds holding TMO

Sandy Spring Bank's TMO Position: Q1 2025 in Review

Sandy Spring Bank reduced its Thermo Fisher Scientific (TMO) stake by 1.3% in Q1 2025, selling an estimated $214K and leaving 29,208 shares worth $14.5M. The position accounts for 0.61% of the portfolio, ranked #35.

Sandy Spring Bank first reported a position in TMO in Q4 2014 and has held it in 42 quarters since. The position peaked at $19.2M in Q4 2021. 2,571 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

  • Sandy Spring Bank held 29,208 shares of Thermo Fisher Scientific worth $14.5M as of Q1 2025.
  • Sandy Spring Bank sold 396 Thermo Fisher Scientific shares in Q1 2025, an estimated $214K.
  • Thermo Fisher Scientific made up 0.61% of Sandy Spring Bank's portfolio in Q1 2025, its #35 holding.
  • Sandy Spring Bank first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 42 quarters since.
  • Sandy Spring Bank's Thermo Fisher Scientific position peaked at $19.2M in Q4 2021.
  • 2,571 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.